Intraocular Pressure Telemetry for Managing Glaucoma During the COVID-19 Pandemic.
Identifieur interne : 000602 ( Main/Corpus ); précédent : 000601; suivant : 000603Intraocular Pressure Telemetry for Managing Glaucoma During the COVID-19 Pandemic.
Auteurs : Kaweh Mansouri ; Inga Kersten-Gomez ; Esther M. Hoffmann ; Peter Szurman ; Lars Choritz ; Robert N. WeinrebSource :
- Ophthalmology. Glaucoma [ 2589-4196 ] ; 2020.
Abstract
PURPOSE
To evaluate in glaucoma patients the feasibility and use of remote monitoring of intraocular pressure (IOP) with an implanted telemetry sensor during the COVID-19 lockdown period.
DESIGN
Cross-sectional study.
SUBJECTS
Patients previously implanted with a telemetric IOP sensor (eyemate®, Implandata GmbH, Hannover, Germany) were included.
METHODS
IOP measurements acquired by the patients during the lockdown period were collected by physicians who were located remotely. A questionnaire was sent to 10 participating study centers to evaluate the clinical impact of remote monitoring of IOP via the IOP sensor system.
MAIN OUTCOME MEASURES
Number of patients who obtained home IOP measurements.
RESULTS
Data were available from all centers and from 37 eyes of 37 patients (16 patients with a sulcus-based sensor and 21 patients with a suprachoroidal sensor). 34 patients obtained IOP measurements during the lockdown period. Mean age of patients was 69.3 ± 9.6 years and 48.6 % were female. A total of 8415 IOP measurements from 370 measurement days were obtained. Based on remote IOP measurements, treatment was changed in 5 patients. In another 5 cases, treatment change was considered when physicians received the IOP measurements after the lockdown period. Nine out of the 10 study centers judged remote IOP measurements to have been clinically impactful.
CONCLUSIONS
These results show the feasibility of patient acquired measurement of IOP in conjunction with remote IOP monitoring by physicians as feasible with an implantable sensor. The data obtained had an impact on clinical decision-making, including adjustment of ocular hypotensive therapy and avoiding unnecessary office visits during the COVID-19 pandemic.
DOI: 10.1016/j.ogla.2020.12.008
PubMed: 33358988
Links to Exploration step
pubmed:33358988Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Intraocular Pressure Telemetry for Managing Glaucoma During the COVID-19 Pandemic.</title>
<author><name sortKey="Mansouri, Kaweh" sort="Mansouri, Kaweh" uniqKey="Mansouri K" first="Kaweh" last="Mansouri">Kaweh Mansouri</name>
<affiliation><nlm:affiliation>Glaucoma Research Center, Montchoisi Clinic, Swiss Visio Network, Lausanne, Switzerland; Department of Ophthalmology, University of Colorado School of Medicine, Denver, CO, USA. Electronic address: kwmansouri@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kersten Gomez, Inga" sort="Kersten Gomez, Inga" uniqKey="Kersten Gomez I" first="Inga" last="Kersten-Gomez">Inga Kersten-Gomez</name>
<affiliation><nlm:affiliation>University Eye Hospital, Ruhr University Bochum, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hoffmann, Esther M" sort="Hoffmann, Esther M" uniqKey="Hoffmann E" first="Esther M" last="Hoffmann">Esther M. Hoffmann</name>
<affiliation><nlm:affiliation>Department of Ophthalmology, University Medical Center, Mainz, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Szurman, Peter" sort="Szurman, Peter" uniqKey="Szurman P" first="Peter" last="Szurman">Peter Szurman</name>
<affiliation><nlm:affiliation>Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Choritz, Lars" sort="Choritz, Lars" uniqKey="Choritz L" first="Lars" last="Choritz">Lars Choritz</name>
<affiliation><nlm:affiliation>Department of Ophthalmology, University of Magdeburg, Magdeburg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Weinreb, Robert N" sort="Weinreb, Robert N" uniqKey="Weinreb R" first="Robert N" last="Weinreb">Robert N. Weinreb</name>
<affiliation><nlm:affiliation>Hamilton Glaucoma Center, Shiley Eye Institute and Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33358988</idno>
<idno type="pmid">33358988</idno>
<idno type="doi">10.1016/j.ogla.2020.12.008</idno>
<idno type="wicri:Area/Main/Corpus">000602</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000602</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Intraocular Pressure Telemetry for Managing Glaucoma During the COVID-19 Pandemic.</title>
<author><name sortKey="Mansouri, Kaweh" sort="Mansouri, Kaweh" uniqKey="Mansouri K" first="Kaweh" last="Mansouri">Kaweh Mansouri</name>
<affiliation><nlm:affiliation>Glaucoma Research Center, Montchoisi Clinic, Swiss Visio Network, Lausanne, Switzerland; Department of Ophthalmology, University of Colorado School of Medicine, Denver, CO, USA. Electronic address: kwmansouri@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kersten Gomez, Inga" sort="Kersten Gomez, Inga" uniqKey="Kersten Gomez I" first="Inga" last="Kersten-Gomez">Inga Kersten-Gomez</name>
<affiliation><nlm:affiliation>University Eye Hospital, Ruhr University Bochum, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hoffmann, Esther M" sort="Hoffmann, Esther M" uniqKey="Hoffmann E" first="Esther M" last="Hoffmann">Esther M. Hoffmann</name>
<affiliation><nlm:affiliation>Department of Ophthalmology, University Medical Center, Mainz, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Szurman, Peter" sort="Szurman, Peter" uniqKey="Szurman P" first="Peter" last="Szurman">Peter Szurman</name>
<affiliation><nlm:affiliation>Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Choritz, Lars" sort="Choritz, Lars" uniqKey="Choritz L" first="Lars" last="Choritz">Lars Choritz</name>
<affiliation><nlm:affiliation>Department of Ophthalmology, University of Magdeburg, Magdeburg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Weinreb, Robert N" sort="Weinreb, Robert N" uniqKey="Weinreb R" first="Robert N" last="Weinreb">Robert N. Weinreb</name>
<affiliation><nlm:affiliation>Hamilton Glaucoma Center, Shiley Eye Institute and Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Ophthalmology. Glaucoma</title>
<idno type="eISSN">2589-4196</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>PURPOSE</b>
</p>
<p>To evaluate in glaucoma patients the feasibility and use of remote monitoring of intraocular pressure (IOP) with an implanted telemetry sensor during the COVID-19 lockdown period.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>DESIGN</b>
</p>
<p>Cross-sectional study.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>SUBJECTS</b>
</p>
<p>Patients previously implanted with a telemetric IOP sensor (eyemate®, Implandata GmbH, Hannover, Germany) were included.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>IOP measurements acquired by the patients during the lockdown period were collected by physicians who were located remotely. A questionnaire was sent to 10 participating study centers to evaluate the clinical impact of remote monitoring of IOP via the IOP sensor system.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>MAIN OUTCOME MEASURES</b>
</p>
<p>Number of patients who obtained home IOP measurements.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Data were available from all centers and from 37 eyes of 37 patients (16 patients with a sulcus-based sensor and 21 patients with a suprachoroidal sensor). 34 patients obtained IOP measurements during the lockdown period. Mean age of patients was 69.3 ± 9.6 years and 48.6 % were female. A total of 8415 IOP measurements from 370 measurement days were obtained. Based on remote IOP measurements, treatment was changed in 5 patients. In another 5 cases, treatment change was considered when physicians received the IOP measurements after the lockdown period. Nine out of the 10 study centers judged remote IOP measurements to have been clinically impactful.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>These results show the feasibility of patient acquired measurement of IOP in conjunction with remote IOP monitoring by physicians as feasible with an implantable sensor. The data obtained had an impact on clinical decision-making, including adjustment of ocular hypotensive therapy and avoiding unnecessary office visits during the COVID-19 pandemic.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">33358988</PMID>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-4196</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Dec</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Ophthalmology. Glaucoma</Title>
<ISOAbbreviation>Ophthalmol Glaucoma</ISOAbbreviation>
</Journal>
<ArticleTitle>Intraocular Pressure Telemetry for Managing Glaucoma During the COVID-19 Pandemic.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">S2589-4196(20)30326-4</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ogla.2020.12.008</ELocationID>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate in glaucoma patients the feasibility and use of remote monitoring of intraocular pressure (IOP) with an implanted telemetry sensor during the COVID-19 lockdown period.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Cross-sectional study.</AbstractText>
<AbstractText Label="SUBJECTS" NlmCategory="METHODS">Patients previously implanted with a telemetric IOP sensor (eyemate®, Implandata GmbH, Hannover, Germany) were included.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">IOP measurements acquired by the patients during the lockdown period were collected by physicians who were located remotely. A questionnaire was sent to 10 participating study centers to evaluate the clinical impact of remote monitoring of IOP via the IOP sensor system.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Number of patients who obtained home IOP measurements.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Data were available from all centers and from 37 eyes of 37 patients (16 patients with a sulcus-based sensor and 21 patients with a suprachoroidal sensor). 34 patients obtained IOP measurements during the lockdown period. Mean age of patients was 69.3 ± 9.6 years and 48.6 % were female. A total of 8415 IOP measurements from 370 measurement days were obtained. Based on remote IOP measurements, treatment was changed in 5 patients. In another 5 cases, treatment change was considered when physicians received the IOP measurements after the lockdown period. Nine out of the 10 study centers judged remote IOP measurements to have been clinically impactful.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results show the feasibility of patient acquired measurement of IOP in conjunction with remote IOP monitoring by physicians as feasible with an implantable sensor. The data obtained had an impact on clinical decision-making, including adjustment of ocular hypotensive therapy and avoiding unnecessary office visits during the COVID-19 pandemic.</AbstractText>
<CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mansouri</LastName>
<ForeName>Kaweh</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Glaucoma Research Center, Montchoisi Clinic, Swiss Visio Network, Lausanne, Switzerland; Department of Ophthalmology, University of Colorado School of Medicine, Denver, CO, USA. Electronic address: kwmansouri@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kersten-Gomez</LastName>
<ForeName>Inga</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>University Eye Hospital, Ruhr University Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hoffmann</LastName>
<ForeName>Esther M</ForeName>
<Initials>EM</Initials>
<AffiliationInfo><Affiliation>Department of Ophthalmology, University Medical Center, Mainz, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Szurman</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Choritz</LastName>
<ForeName>Lars</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Department of Ophthalmology, University of Magdeburg, Magdeburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Weinreb</LastName>
<ForeName>Robert N</ForeName>
<Initials>RN</Initials>
<AffiliationInfo><Affiliation>Hamilton Glaucoma Center, Shiley Eye Institute and Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>12</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Ophthalmol Glaucoma</MedlineTA>
<NlmUniqueID>101730510</NlmUniqueID>
<ISSNLinking>2589-4196</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>10</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>12</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>12</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>12</Month>
<Day>28</Day>
<Hour>10</Hour>
<Minute>42</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>12</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>12</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33358988</ArticleId>
<ArticleId IdType="pii">S2589-4196(20)30326-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.ogla.2020.12.008</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/LockdownV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000602 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000602 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= LockdownV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:33358988 |texte= Intraocular Pressure Telemetry for Managing Glaucoma During the COVID-19 Pandemic. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33358988" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LockdownV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |